The Fed seems to be doing everything in its capacity to desperately curb the fears of recession. While tech stocks are getting beat up due to poor results and forecast its important to have a balanced portfolio. It seems that economy may take its own sweet time to recover as yesterday’s GDP data suggested that […]
AMGN
GPO Plus (OTCQB:GPOX) could be a rising star in the health care industry
Inflation is back. It’s back in a major way. The consumer price index for all items rose 0.6% in January, driving up annual inflation by 7.5%. That marked the biggest gain since February 1982 and was even higher than the Wall Street estimate. (3) It’s taking its toll on everyone from manufacturers to businesses to […]
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK)
With the spotlight firmly on Covid variants, it’s easy to lose sight of what will probably be the most important segment of the biopharma space over the next ten years: oncology. This is where the biggest success stories will be found. It’s where the largest revolutions will happen. It’s the epicenter of the most important […]
Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries
Amgen, Inc. (NASDAQ:AMGN) and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune diseases. The unrevealed target and lead inhibitors were found out through the Array’s proprietary podium that leverages its capability in chemistry and early development. Array Biopharma made a deal with […]
Brainstorm Cell Therapeutics Catches Lightning (BCLI)
After months of bobbing above its annual low of $0.20, Brainstorm Cell Therapeutics (OTC: BCLI) broke the recent waterline for a gain of a nickel on the heaviest volume seen in over a month. The stock closed the trading session at $0.33, or a 19% move to the upside on the day, and a tad […]
